Status:
COMPLETED
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Institute of Dental and Craniofacial Research (NIDCR)
Conditions:
Skin Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical research study is to evaluate an experimental imaging technology, the multispectral digital microscope (MDM), which may help doctors see how far skin cancer extends (widens o...
Detailed Description
All tissue and cells are made of tiny particles that give off small amounts of light. This light is called fluorescence. Researchers have learned that cancerous cells and normal cells give off differe...
Eligibility Criteria
Inclusion
- Patients who will be undergoing surgery to remove a region of skin suspected of containing non-melanoma skin cancer will be eligible to participate in this study. The proposed resection should be equal or greater than 1 cm in diameter.
- In addition, patients undergoing induction chemotherapy or biologic therapy prior to surgical resection are also eligible.
- Patients must sign an informed consent indicating awareness of the investigational nature of this study.
Exclusion
- Patients with non-melanoma skin cancer lesion at eyelid, or in case that the lesion extends to superior or inferior eyelid, this area will not be imaged.
- Persons who are medically unfit to undergo resection of skin lesions.
- Persons under the age of 18.
Key Trial Info
Start Date :
January 30 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2017
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00432471
Start Date
January 30 2007
End Date
June 25 2017
Last Update
June 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030